Legal News Articles - Personal Injury
August 14, 2017. By Anne Wallace.
Washington, DC: Plaintiffs have now filed more than 1,400 Propecia lawsuits alleging that the drug, also known as finasteride, caused a variety of side effects, including sexual dysfunction, depression and cognitive disorders. These symptoms may persist even after the drug is discontinued.Read [ Propecia Lawsuit Plaintiffs Should Brace for Statute of Limitations Fight ]
August 14, 2017. By Brenda Craig.
Atlanta, GA: In May 2015, Cynthia Ziegler from Brookhaven, Georgia received a devastating diagnosis from her doctor. Ziegler had stage IV lung cancer and there was no reason for optimism. Until that day Ziegler had no idea there was a dangerous cancer lurking in her chest.Read [ Cancer Patient Files Lawsuit for Delayed Diagnosis ]
August 12, 2017. By Gordon Gibb.
Dartmouth, NS: It might be argued that an 86-year-old individual shouldn’t be spending his twilight years suffering debilitating pain and surgical mesh complications from an allegedly defective surgical product. But such is the fate of a Canadian man who alleges that Ethicon Physiomesh, which has been recalled by Health Canada, is responsible for his suffering.Read [ Pain from Surgical Mesh Complications Dropped Physiomesh Patient “To My Knees” ]
August 12, 2017. By Brenda Craig.
Toronto, Ontario Thousands of Canadians and American cardiac arrhythmia patients with implantable defibrillators powered by faulty ion batteries and manufactured by St. Jude’s Medical Inc. and St. Jude’s Medical Canada are or will soon be eligible to join class actions suits in Canada and the US.Read [ Implantable Defibrillators with Faulty Batteries Lead to Class Action ]
August 11, 2017. By Anne Wallace.
Washington, DC:Saxagliptin lawsuit plaintiffs just got a big victory. The fact that they can sue in California courts under California law will affect whether and how much they can recover for the injuries they have suffered.Read [ California Saxagliptin Lawsuit Plaintiffs Score Big Procedural Win ]
August 10, 2017. By Brenda Craig.
Houston, TX Users of the blood pressure medication Benicar will receive an estimated average payout of $100,000 each in a settlement deal reached with Diiachi Sankyo and Forest Laboratories. The company admits no liability but agreed to pay compensation plaintiffs to some individuals who experienced gastrointestinal problems after using the medication.Read [ Deadline Set in $300 Million Settlement in Benicar Lawsuit – Short Window! ]
August 9, 2017. By Jane Mundy.
New Orleans, LA: This is Frank’s story about his son Frankie, who was prescribed Risperdal to treat ADHD when he 11 years old. (Risperdal is frequently prescribed off-label for uses not approved by the FDA.) By the time Frankie was 16, he had developed “female boobs” or gynecomastia. Frank’s son was incarcerated at 18 years of age and he will be eligible for parole in three years, when he is 29 years old.Read [ Father Worries about his Incarcerated Son with Risperdal “Female Boobs” ]
August 9, 2017. By Jane Mundy.
Vancouver, BC: I drive a Subaru because it consistently gets top marks in safety from Consumers Reports and the insurance industry. It constantly gets "top safety pick” by the Insurance Institute for Highway Safety. And it looks good. But all these years that I’ve been driving a Subaru, it never occurred to me that there was a risk of airbag injury.Read [ Airbag Recall: My Subaru Passengers in the Back Seat ]
August 9, 2017. By Brenda Craig.
Baltimore, MD In a controversial ruling, a US District Court judge in Maryland has ruled US Veterans and their families cannot sue KBR contracting for exposing American soldiers to plumes of toxic smoke that emanated from burn pits used to dispose of trash near US military bases in Afghanistan and Iraq.Read [ Contractor Not to Blame for Veterans’ Health Problems ]
August 8, 2017. By Gordon Gibb.
Washington, DC: A drug indicated for the treatment of type 2 diabetes already carries warnings for compelling adverse reactions including a heightened risk for lower limb amputations, kidney failure, diabetic ketoacidosis and cardiovascular injuries. To that end, the FDA warns of fracture risk with Invokana and Invokamet. Yet in spite of such serious side effects associated with Invokana (canagliflozin) and Invokamet (canagliflozin and metformin), the US Food and Drug Administration (FDA) approved, last year an expanded indication for Invokamet.Read [ Are Risk of Invokana and Invokamet Bone Fractures a Sign of Fractured Regulations? ]